Apolipoprotein E and cognitive change in an elderly population

Area of Science:

• Neuroscience
• Genetics
• Epidemiology

Background:

• The apolipoprotein E (apoE) epsilon 4 allele is linked to increased Alzheimer's disease risk, while the epsilon 2 allele is underrepresented.
• Understanding the impact of apoE genotypes on cognitive function in the general elderly population is crucial for risk assessment.

Purpose of the Study:

• To investigate the association between apolipoprotein E (apoE) genotypes (epsilon 4 and epsilon 2) and the risk of cognitive impairment in older adults.
• To determine the predictive value of apoE genotyping for cognitive decline over a 4- to 7-year period.

Main Methods:

• A population-based sample of 1,899 individuals aged 65+ was studied.
• Multiple regression and logistic regression analyses were used to assess the effects of apoE genotypes on cognitive performance, specifically delayed recall.
• Cognitive impairment risk was evaluated based on apoE epsilon 4 and epsilon 2 allele presence.

Main Results:

• Both apoE epsilon 4 and apoE epsilon 2 alleles significantly predicted performance on a delayed recall task.
• The odds ratio for cognitive impairment was approximately 1.37 for apoE epsilon 4 and 0.53 for apoE epsilon 2.
• These effects were more pronounced in women, yet 85% of elderly individuals with the apoE E4/4 genotype remained cognitively unimpaired.

Conclusions:

• Apolipoprotein E (apoE) genotyping has a modest effect on predicting cognitive impairment in the general elderly population.
• Despite carrying the apoE epsilon 4 allele, many individuals maintain cognitive function into old age.
• ApoE genotyping is likely to have limited utility as a diagnostic or prognostic tool for cognitive decline.